Recent Advances in Nanoparticle-Based Drug Delivery Strategies to Cross the Blood–Brain Barrier in Targeted Treatment of Alzheimer’s Disease

Pharmaceutics 2026 Open access

Read full text
Authors: Hoa Le, Giang T. T. Vu, Amos Olusegun Abioye, Adeboye Adejare
DOI: 10.3390/pharmaceutics18020192
Cited by: 6
References: 185

Abstract

The blood–brain barrier (BBB) is a major obstacle to the development of brain-targeted drug delivery systems, restricting greater than 98% of small molecules (

Fields of Study & Subjects

Nanoparticle-Based Drug Delivery Barrier Structure and Function Studies Alzheimer's disease research and treatments

Publication details

Journal / source
Pharmaceutics
Publisher
MDPI AG
Volume
18
Issue
2
Pages
192–192
Publication date
1 February 2026
Language
EN